loader image
Saturday, December 20, 2025
61.5 F
McAllen
- Advertisement -

Another 3 Common Pesticides Are Now Linked To Parkinson’s Disease Risk

Translate to Spanish or other 102 languages!

Three more pesticides commonly used in the United States have now been linked to heightened Parkinson’s risk. Image for illustration purposes
Three more pesticides commonly used in the United States have now been linked to heightened Parkinson’s risk. Image for illustration purposes
- Advertisement -
  • Parkinson’s disease prevalence is growing fast, and similar to some other neurological conditions, its causes are unclear. 
  • The potential impact of chemicals that are toxic to neurons in the part of the brain affected by Parkinson’s disease has been investigated since the 1980s. 
  • Despite this, many chemicals, particularly pesticides and herbicides that are known to pose a risk, are still used in many parts of the world. 
  • Researchers have now identified a risk of Parkinson’s disease associated with exposure to 14 pesticides. 

Parkinson’s disease is the fastest growingTrusted Source neurological disorder in the world at present, and the reason why is unclear.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/another-3-common-pesticides-are-now-linked-to-parkinsons-disease-risk?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-03-11&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
×